Pharmaceutical revenue in Italy in 2022, by reimbursable or non-reimbursable drugs
In 2022, the total pharmaceutical market revenue in Italy amounted to approximately 17 billion euros. This statistic breaks down this figure, making a distinction between drugs that are reimbursable by the Italian National Health System and those that are not. According to the data, the market for reimbursable drugs generated a much larger volume of revenue, with a value of more than 11 billion euros. The revenue related to non-reimbursable drugs, instead, was equal to roughly six billion euros.